PHARMA MARINE AS

6280 SØVIK

Finances

Return on Equity

45,29 %

Current Ratio

1,64

Debt-to-Equity Ratio

0,62

Key figures (NOK)	2022	2021	2020	2019
Revenue	329 741 000	265 150 000	216 652 000	178 603 000
Net Income	54 493 000	31 230 000	7 839 000	8 253 000
Total Assets	330 360 000	260 210 000	249 822 000	251 013 000
Total Equity	120 333 000	112 841 000	95 611 000	87 773 000

Income (NOK)	2022	2021	2020	2019
Revenue	329 741 000	265 150 000	216 652 000	178 603 000
Expenditure	239 183 000	218 426 000	200 269 000	175 584 000
Operating Profit	78 759 000	41 665 000	15 543 000	16 395 000
Financial Income	137 000	2 986 000	481 000	3 887 000
Financial Costs	8 904 000	4 475 000	5 863 000	10 200 000
Financial Balance	−8 767 000	−1 489 000	−5 382 000	−6 313 000
Earnings Before Tax	69 993 000	40 176 000	10 160 000	10 082 000
Tax	15 500 000	8 947 000	2 321 000	1 829 000
Net Income	54 493 000	31 230 000	7 839 000	8 253 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	109 252 000	103 498 000	120 177 000	124 986 000
Total Current Assets	221 108 000	156 712 000	129 645 000	126 027 000
Total Assets	330 360 000	260 210 000	249 822 000	251 013 000
Total Retained Equity	46 325 000	38 833 000	21 603 000	13 765 000
Total Equity	120 333 000	112 841 000	95 611 000	87 773 000
Total Long-Term Debt	74 809 000	76 706 000	84 276 000	86 655 000
Total Current Debt	135 218 000	70 664 000	69 935 000	76 585 000
Total Equity and Debt	330 360 000	260 210 000	249 822 000	251 013 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	329 223 000	262 707 000	216 402 000	176 462 000
Other Income	518 000	2 443 000	250 000	2 141 000
Revenue	329 741 000	265 150 000	216 652 000	178 603 000
Cost of Goods Sold	117 550 000	110 101 000	112 145 000	93 310 000
Salary Costs	44 060 000	38 013 000	32 363 000	25 034 000
Depreciation	9 433 000	9 637 000	9 596 000	8 803 000
Impairment	0	0	0	0
Expenditure	239 183 000	218 426 000	200 269 000	175 584 000
Operating Profit	78 759 000	41 665 000	15 543 000	16 395 000
Financial Income	137 000	2 986 000	481 000	3 887 000
Financial Costs	8 904 000	4 475 000	5 863 000	10 200 000
Financial Balance	−8 767 000	−1 489 000	−5 382 000	−6 313 000
Dividends	27 000 000	0	0	0
Net Income	54 493 000	31 230 000	7 839 000	8 253 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	246 000	246 000	246 000	845 000
Real Eastate	1 448 000	66 000	10 750 000	0
Machinery and Plant Facilities	103 142 000	98 616 000	105 576 000	120 470 000
Fixtures	2 167 000	2 319 000	1 355 000	1 421 000
Total Tangible Assets	106 756 000	101 002 000	117 681 000	121 891 000
Total Fiancial Fixed Assets	2 250 000	2 250 000	2 250 000	2 250 000
Total Fixed Assets	109 252 000	103 498 000	120 177 000	124 986 000
Stock	161 945 000	86 637 000	77 423 000	64 191 000
Total Investments	0	0	0	0
Cash, Bank	1 578 000	1 705 000	1 134 000	900 000
Total Current Assets	221 108 000	156 712 000	129 645 000	126 027 000
Total Assets	330 360 000	260 210 000	249 822 000	251 013 000
Total Equity	120 333 000	112 841 000	95 611 000	87 773 000
Short-Term Group Debt	117 000	0	0	0
Total Long-Term Debt	74 809 000	76 706 000	84 276 000	86 655 000
Creditors	33 354 000	36 594 000	15 036 000	20 593 000
Unpaid Taxes	2 900 000	2 518 000	2 015 000	1 679 000
Dividends	27 000 000	0	0	0
Other Current Debt	11 387 000	8 819 000	4 650 000	5 044 000
Total Current Debt	135 218 000	70 664 000	69 935 000	76 585 000
Total Equity and Debt	330 360 000	260 210 000	249 822 000	251 013 000

Financial indicators	2022	2021	2020	2019
Return on Equity	45,29 %	27,68 %	8,2 %	9,4 %
Debt-to-Equity Ratio	0,62	0,68	0,88	0,99
Operating Profit Margin	23,89 %	15,71 %	7,17 %	9,18 %
Current Ratio	1,64	2,22	1,85	1,65
Quick Ratio	−8,27	−9,81	−17,31	10,17
Equity Ratio	0,36	0,43	0,38	0,35
Gross Profit Margin	64,35 %	58,48 %	48,24 %	47,76 %